Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

MolMed

MolMed
1996 FOUNDED
PUBLIC STATUS
201-300 EMPLOYEES
MLM STOCK SYMBOL
1 INVESTMENTS
$0.38 SHARE PRICE (As of Friday Closing)
Description

Molmed SpA is an Italy based medical biotechnology company. It is engaged in research, development and clinical validation of innovative therapies to treat cancer. The company's therapies include TK for blood cancers and NGR-hTNF for solid tumors. Its pipeline includes antitumor therapeutics in clinical and preclinical development.

Website
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Stock Exchange
MIL
Primary Office
  • Via Olgettina 58
  • 20132 Milan
  • Italy

+39 0000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore MolMed’s full profile, request a free trial.

MolMed Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.30 - $0.52 $175M $0.39 1.41M 463M

MolMed Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 175,775 121,948 238,337 161,549
Revenue 38,163 33,569 25,939 21,552
EBITDA 1,293 (3,050) (8,084) (14,150)
Net Income (1,871) (4,865) (9,583) (15,349)
Total Assets 46,550 51,688 49,326
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

MolMed Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore MolMed‘s full profile, request access.

Request full access to PitchBook

MolMed Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 01-Jan-2002 000000000000000000 Biotechnology
To view this company’s complete investment and acquisition history, request access »

MolMed Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore MolMed‘s full profile, request access.

Request full access to PitchBook

MolMed Executive Team (4)

Name Title Board
Seat
Contact
Info
Riccardo Palmisano Chief Executive Officer
Salvatore Calabrese Chief Financial Officer & Director, Administration, Finance & Control
Germano Carganico Executive Director, Strategic Affairs
Claudio Bordignon MD Founder & Chairman

MolMed Board Members (13)

Name Representing Role Since Contact
Info
0000000 00000000 MolMed Board Member 000 0000
0000000 0000000 MolMed Board Member 000 0000
00000 0000000 00 Self Chairman 000 0000
0000000 000000000 00 MolMed Founder & Chairman 000 0000
00000 0000000000 Self Board Member 000 0000

6 Former Board Members

You’re viewing 5 of 13 board members. Get the full list »